Risk-free and remarkably productive vaccines are available for two viral STIs: hepatitis B and HPV. These vaccines have represented major innovations in STI prevention. By the top of 2023, the HPV vaccine had been launched as part of regime immunization programmes in 140countries, principally large- and Center-profits nations around the https://us.hc6.org/